C4 therapeutics to participate in the virtual ubs targeted protein degradation day

Watertown, mass., july 08, 2024 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that c4t management will participate in a fireside chat at the ubs targeted protein degradation (tpd) day taking place virtually on july 15, 2024.
CCCC Ratings Summary
CCCC Quant Ranking